MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Balance Sheets Overview
Current Ratio
290.09%
Quick Ratio
246.41%
Cash Ratio
131.69%
Debt to Asset Ratio
27.21%
Unit: Thousand (K) dollars
Assets Breakdown
Long-term marketable securities
Cash and cash equivalents
Deferred tax assets
Others
Liabilities Breakdown
Retained earnings
Additional paid-in capital
Accrued expenses
Others
Subscribe for Financial Insights
Page 1
Annual
123
Page 1
Balance Sheets
2025-12-31
2024-12-31
2023-12-31
2022-12-31
Cash and cash equivalents
5,084,800
4,569,600
10,369,100
10,504,000
Marketable securities
1,523,300
1,546,300
849,200
274,500
Accounts receivable, net
2,052,800
1,609,400
1,563,400
1,442,200
Inventories
1,686,800
1,205,400
738,800
460,600
Prepaid expenses and other current assets
853,300
665,700
623,700
553,500
Total current assets
11,201,000
9,596,400
14,144,200
13,234,800
Property and equipment, net
1,520,300
1,227,800
1,159,300
1,108,400
Goodwill
1,088,000
1,088,000
1,088,000
1,088,000
Other intangible assets, net
424,200
825,900
839,900
603,600
Deferred tax assets
2,897,900
2,331,100
1,812,100
1,246,900
Operating lease assets
1,562,700
1,356,800
293,600
347,400
Long-term marketable securities
5,712,300
5,107,900
2,497,800
-
Other assets
1,236,600
999,300
895,300
521,800
Total assets
25,643,000
22,533,200
22,730,200
18,150,900
Accounts payable
461,700
413,000
364,900
303,900
Accrued expenses
2,971,200
2,788,600
2,655,300
2,126,700
Other current liabilities
428,300
363,000
527,200
311,500
Total current liabilities
3,861,200
3,564,600
3,547,400
2,742,100
Long-term finance lease liabilities
-
112,800
376,100
430,800
Long-term operating lease liabilities
1,846,500
1,544,400
348,600
379,500
Other long-term liabilities
1,269,500
901,800
877,700
685,800
Total liabilities
6,977,200
6,123,600
5,149,800
4,238,200
Common stock, 0.01 par value 500,000,000 shares authorized, 253,991,224 and 256,940,382 shares issued and outstanding, respectively
2,500
2,600
2,600
2,600
Additional paid-in capital
5,119,200
6,672,400
7,449,700
7,386,500
Accumulated other comprehensive (loss) income
-15,900
127,800
-14,300
800
Retained earnings
13,560,000
9,606,800
10,142,400
6,522,800
Total shareholders equity
18,665,800
16,409,600
17,580,400
13,912,700
Total liabilities and shareholders equity
25,643,000
22,533,200
22,730,200
18,150,900
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS).
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Balance Sheets
Cash and cash
equivalents
$5,084,800K
(11.27%↑ Y/Y)
Accounts receivable, net
$2,052,800K
(27.55%↑ Y/Y)
Inventories
$1,686,800K
(39.94%↑ Y/Y)
Marketable securities
$1,523,300K
(-1.49%↓ Y/Y)
Prepaid expenses and
other current assets
$853,300K
(28.18%↑ Y/Y)
Total current assets
$11,201,000K
(16.72%↑ Y/Y)
Long-term marketable
securities
$5,712,300K
(11.83%↑ Y/Y)
Deferred tax assets
$2,897,900K
(24.31%↑ Y/Y)
Operating lease assets
$1,562,700K
(15.18%↑ Y/Y)
Property and equipment,
net
$1,520,300K
(23.82%↑ Y/Y)
Other assets
$1,236,600K
(23.75%↑ Y/Y)
Goodwill
$1,088,000K
(0.00%↑ Y/Y)
Other intangible
assets, net
$424,200K
(-48.64%↓ Y/Y)
Total assets
$25,643,000K
(13.80%↑ Y/Y)
Total liabilities and
shareholders equity
$25,643,000K
(13.80%↑ Y/Y)
Total shareholders
equity
$18,665,800K
(13.75%↑ Y/Y)
Total liabilities
$6,977,200K
(13.94%↑ Y/Y)
Accumulated other
comprehensive (loss) income
-$15,900K
(-112.44%↓ Y/Y)
Retained earnings
$13,560,000K
(41.15%↑ Y/Y)
Additional paid-in capital
$5,119,200K
(-23.28%↓ Y/Y)
Total current
liabilities
$3,861,200K
(8.32%↑ Y/Y)
Long-term operating lease
liabilities
$1,846,500K
(19.56%↑ Y/Y)
Other long-term
liabilities
$1,269,500K
(40.77%↑ Y/Y)
Common stock, 0.01 par
value 500,000,000...
$2,500K
(-3.85%↓ Y/Y)
Accrued expenses
$2,971,200K
(6.55%↑ Y/Y)
Accounts payable
$461,700K
(11.79%↑ Y/Y)
Other current
liabilities
$428,300K
(17.99%↑ Y/Y)
Buy us a coffee
logo-vertex-inc-svg copy-svg
VERTEX PHARMACEUTICALS INC MA (VRTX)
logo-vertex-inc-svg copy-svg
VERTEX PHARMACEUTICALS INC MA (VRTX)